MedTrace Logo

Does a Minimally Invasive Approach to Liver Resection Improve Postoperative Outcomes?

NCT07169877 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9411

Last updated 2025-09-12

No results posted yet for this study

Summary

A retrospective cohort study was conducted using the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) database to identify adult patients who underwent liver resection between 2022 and 2023. Primary outcomes included 30-day mortality, sepsis, septic shock, readmission, and reoperation.

Conditions

  • Hepatic Neoplasms

Sponsors & Collaborators

Principal Investigators

  • Michael Leitman, MD · Icahn School of Medicine at Mount Sinai

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07169877 on ClinicalTrials.gov